The Risk of Recurrent Venous Thromboembolism in Heterozygous Carriers of Factor V Leiden and a First Spontaneous Venous Thromboembolism | Zendy

Sabine Eichinger | Zendy; Ansgar Weltermann | Zendy; Christine Mannhalter | Zendy; Erich Minar | Zendy; Christine Bialonczyk | Zendy; Mirko Hirschl | Zendy; Verena Schönauer | Zendy; Klaus Lechner | Zendy; Paul A. Kyrle | Zendy

Open Access

The Risk of Recurrent Venous Thromboembolism in Heterozygous Carriers of Factor V Leiden and a First Spontaneous Venous Thromboembolism

Author(s) -

Sabine Eichinger,

Ansgar Weltermann,

Christine Mannhalter,

Erich Minar,

Christine Bialonczyk,

Mirko Hirschl,

Verena Schönauer,

Klaus Lechner,

Paul A. Kyrle

Publication year - 2002

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.162.20.2357

Subject(s) - medicine , factor v leiden , pulmonary embolism , discontinuation , venous thrombosis , risk factor , relative risk , factor v , confidence interval , gastroenterology , lupus anticoagulant , venous thromboembolism , thrombosis , thrombophilia , surgery

Factor V (FV) Leiden is a risk factor for venous thrombosis (VT). Data on its influence on the risk of recurrent venous thromboembolism (VTE) are controversial owing to different study designs and patient cohorts.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research